Cardiac magnetic resonance myocardial perfusion imaging for detection of functionally significant obstructive coronary artery disease: A prospective study
Introduction
Coronary artery disease (CAD) is one of the major causes of morbidity and mortality in western countries [1]. Since CAD is treatable, efforts must focus on prevention and detection of the early stages of disease, avoiding progression to irreversible damage (myocardial infarction and heart failure) [2], [3]. Therefore, it is essential to develop reliable non-invasive methods, capable to correctly identify the presence of CAD and to guide management [4]. Nuclear Imaging and Stress Echocardiography are most established for the diagnosis of myocardial ischemia. However, these techniques are limited by low spatial resolution and/or exposure to ionizing radiation [5]. Single-photon emission computerized tomography (SPECT) is limited by attenuation artifacts contributing to false positive and balanced ischemia may lead to false negative results in the presence of multivessel disease. In recent years, cardiac magnetic resonance myocardial perfusion imaging (CMR-MPI) has evolved into a robust technique and is starting to challenge previously established methods [6]. CMR-MPI integrates anatomic and functional information in a single exam, with high spatial and temporal resolution [7] without exposing the patient to harmful radiation [8], [9]. It compares favorably to SPECT, positron emission tomography, and invasive coronary angiography (XA) [10], [11], [12]. However, the majority of these studies have been conducted in highly specialized CMR centers and/or academic research facilities. Therefore, one may argue that diagnostic accuracy may not be the same in routine clinical practice of non-academic hospitals. In fact, the discrepant results between the single-center “CE-MARC” trial [13] – showing CMR-MPI superiority over SPECT – and the “MR-IMPACT II” multicenter clinical trial [14] – reporting non-inferiority – highlight the importance of this discussion.
Furthermore, most studies tested CMR-MPI against an anatomical standard as quantitative coronary angiography (QCA) as assessed by XA, which may underestimate the performance of this functional test. Only a few studies compared CMR-MPI against the functional reference-standard, fractional flow reserve (FFR), reporting excellent accuracy for the diagnosis of functionally significant CAD [15], [16].
We thought to evaluate the diagnostic performance of CMR-MPI for ischemia detection in the clinical setting of a tertiary non-academic cardiology center, using invasive FFR as the reference standard.
Section snippets
Population
During a 22-month period (February 2010 to November 2011) we prospectively screened 176 consecutive patients referred by general physicians to our hospital outpatient cardiology clinic due to clinical suspicion of CAD. Inclusion criteria of the study were: age > 40 years, symptoms compatible with CAD and ≥ 2 risk factors and/or a positive/inconclusive treadmill test. Exclusion criteria included unstable clinical status, previous myocardial infarction, previous coronary artery bypass grafting,
Results
All the 103 patients completed the study protocol without adverse effects. All CMR scans were performed within 9 ± 8 days before XA.
Discussion
The main finding of our study is that CMR-MPI has very good accuracy for the detection of functionally significant CAD in symptomatic patients with intermediate or high pre-test probability. Our results show the high sensitivity and specificity of CMR stress perfusion, both in patient- and in vessel-based analysis. These results were obtained in a real world clinical cardiology setting, using standard, widely available acquisition sequences and a common 1.5 Tesla clinical CMR scanner.
Funding sources
The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.
NB was funded by FCT (Fundação para a Ciência e Tecnologia, Portugal), under grant number SFRH/BD/45989/2008 and received grant support from the Portuguese Society of Cardiology and the
Acknowledgments
The authors would like to thank the radiographers David Monteiro, Nuno Almeida, Júlio Antunes and Pedro Rodrigues, as well as all the nurses involved in patient preparation, for their high-quality continuous support and hard work during the clinical CMR lists. Thanks are extended to the radiographers Mónica Carvalho, Daniel Leite and Wilson Ferreira for imaging management and data support. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing
References (29)
- et al.
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction)
J Am Coll Cardiol
(2004) - et al.
A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
J Am Coll Cardiol
(1999) - et al.
Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X
J Am Coll Cardiol
(2008) - et al.
Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis
Journal of the American College of Cardiology
(2012) - et al.
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
Lancet
(2012) - et al.
High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve
J Am Coll Cardiol
(2011) - et al.
Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease
Am J Med
(1997) - et al.
Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis
J Am Coll Cardiol
(2007) - et al.
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study
J Am Coll Cardiol
(2007) - et al.
Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study
Lancet
(2003)
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase
J Am Coll Cardiol
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization
Circulation
Cardiology TFotMoAMIotESo. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
Eur Heart J
Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease
Eur Heart J
Cited by (32)
Clinical Importance of Quantitative Assessment of Myocardial Blood Flow
2022, Journal of Cardiothoracic and Vascular AnesthesiaStress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week
2021, Journal of the American College of CardiologyUsefulness of stress cardiac magnetic resonance imaging in the diagnosis of ischemic heart disease
2020, FMC Formacion Medica Continuada en Atencion PrimariaComparison of diagnostic accuracy of stress myocardial perfusion imaging for detecting hemodynamically significant coronary artery disease between cardiac magnetic resonance and nuclear medical imaging: A meta-analysis
2019, International Journal of CardiologyCitation Excerpt :Furthermore, the diagnostic accuracy of CMR using a FFR cut-off value of 0.8 or 0.75 was also compared in the present meta-analysis, the results indicated that a higher sensitivity when a FFR cut-off value of 0.75 was used, and a higher specificity when a FFR cut-off value of 0.8 was used. Articles by Watkins et al. [32] and Bettencourt et al. [33] that directly compared the diagnostic accuracy of CMR using a FFR cut-off value of 0.8 or 0.75 in the same patient population also reported the same results at the patient or vessel level. This is not hard to understand because a higher FFR cut-off value used as reference standard, a higher rate of false-negative and lower rate of false-positive numbers would be reported.
Data on diagnostic performance of stress perfusion cardiac magnetic resonance for coronary artery disease detection at the vessel level
2018, Data in BriefCitation Excerpt :Papers were retrieved in Pubmed, Web of Science and the Cochrane Library from inception to 10 September 2017. No search restrictions were applied [12–45]. Detailed description of selection criteria of the papers is described elsewhere [46].
Hemodynamic significance of coronary stenosis by vessel attenuation measurement on CT compared with adenosine perfusion MRI
2015, European Journal of RadiologyCitation Excerpt :Compared to SPECT, there are important advantages of APMR: superior diagnostic accuracy, lack of radiation, and higher spatial resolution, enabling detection of subendocardial perfusion defects [5,27]. Compared to FFR, APMR has an excellent diagnostic accuracy [6,28]. However, the (patho)physiological processes underlying CCO and APMR are different.